Edition:
United States

Hologic Inc (HOLX.OQ)

HOLX.OQ on NASDAQ Stock Exchange Global Select Market

38.30USD
20 Apr 2018
Change (% chg)

$-0.31 (-0.80%)
Prev Close
$38.61
Open
$38.58
Day's High
$38.75
Day's Low
$38.14
Volume
577,099
Avg. Vol
821,103
52-wk High
$46.80
52-wk Low
$35.34

Select another date:

Tue, Mar 27 2018

BRIEF-FDA Approves New Innovations On Hologic's 3Dimensions™ Mammography System

* FDA APPROVES NEW INNOVATIONS ON HOLOGIC'S 3DIMENSIONS™ MAMMOGRAPHY SYSTEM, THE FASTEST, HIGHEST RESOLUTION BREAST TOMOSYNTHESIS SYSTEM EVER(1)

Appeals court hands win to Smith & Nephew in Hologic patent case

A federal appeals court on Wednesday upheld the validity of a surgical tool patent over which medical device maker Smith & Nephew PLC won a $4 million verdict against rival Hologic Inc.

BRIEF-Koninklijke Philips And Hologic Announce Global Partnership Agreement

* PHILIPS AND HOLOGIC ANNOUNCE GLOBAL PARTNERSHIP AGREEMENT TO PROVIDE INTEGRATED IMAGING SOLUTIONS FOR WOMEN'S HEALTH

BRIEF-Hologic Reports Q1 GAAP Earnings Per Share $1.45

* HOLOGIC ANNOUNCES FINANCIAL RESULTS FOR FIRST QUARTER OF FISCAL 2018

BRIEF-Hologic - CEO's 2017 Total Compensation Was $11.2 Million Vs $10.8 Million‍​

* HOLOGIC INC - CEO STEPHEN P. MACMILLAN'S 2017 TOTAL COMPENSATION WAS $11.2 MILLION VERSUS $10.8 MILLION - SEC FILING‍​ Source text: (http://bit.ly/2nhdmKL) Further company coverage:

BRIEF-Third Respiratory Assay now FDA cleared on Hologic's new Panther Fusion system

* THIRD RESPIRATORY ASSAY NOW FDA CLEARED ON HOLOGIC'S NEW PANTHER FUSION® SYSTEM

BRIEF-HOLOGIC RECEIVES FDA 510(K) CLEARANCE OF QUANTRA 2.2 BREAST DENSITY ASSESSMENT SOFTWARE

* HOLOGIC RECEIVES FDA 510(K) CLEARANCE OF QUANTRA 2.2 BREAST DENSITY ASSESSMENT SOFTWARE

BRIEF-Hologic announces upcoming put option

* Hologic announces upcoming put option and notice of redemption of 2.00% convertible senior notes due 2043 Source text for Eikon: Further company coverage:

BRIEF-Hologic announces Q4 GAAP earnings per share $0.29

* Hologic announces financial results for fourth quarter of fiscal 2017

BRIEF-Hologic - ‍received 510(k) clearance from FDA for Panther Fusion Paraflu assay​

* Hologic Inc - ‍received 510(k) clearance from FDA for Panther Fusion Paraflu assay​ Source text for Eikon: Further company coverage:

Select another date: